Combose 0.5 Tablet
Marketer
ADN Life Sciences
Salt Composition
Repaglinide (0.5mg) + Voglibose (0.3mg)
Overview Combose 0.5 Tablet
DiabetaComb 0.5mg tablets combine two medications to manage type 2 diabetes. This treatment helps regulate post-prandial hyperglycemia (high blood sugar after meals). It's prescribed when dietary changes and other similar drugs prove insufficient to control elevated blood glucose. DiabetaComb 0.5mg should be taken immediately following meals; dosage is determined by your physician. Discontinuation requires medical consultation, as abrupt cessation can elevate blood sugar, potentially leading to severe complications such as renal impairment and vision loss. A missed dose should not be doubled; instead, take it with your next meal. Treatment involves a holistic approach encompassing diet, exercise, and weight management as directed by your doctor. Common, usually transient, side effects may include gas, diarrhea, abdominal discomfort, hypoglycemia, and skin reactions. Persistent or bothersome symptoms warrant medical attention. Regular blood glucose monitoring is crucial. Prior to commencing treatment, disclose any kidney, liver, or urinary tract issues, diuretic use, or pregnancy/breastfeeding status. Limit alcohol consumption to minimize potential adverse effects.
Uses of Combose 0.5 Tablet
Managing type 2 diabetes
Major Benefits of Combose 0.5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or divide it. Consume Combose 0.5 Tablet with a meal.
Common Side effects of Combose 0.5 Tablet:
- Hypoglycemia (low blood glucose level)
- Abdominal pain
- Diarrhea
- Flatulence
- Headache
How to use Combose 0.5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.5mg Combose tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Combose 0.5 Tablet works:
Combinazione 0.5mg tablet contains a dual-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Combose 0.5 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Combose 0.5 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Combose 0.5 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Combose 0.5 Tablet. Dosage modification for Combose 0.5 Tablet may be necessary; physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Combose 0.5 mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Combose 0.5 Tablet :
Should you forget a Combose 0.5 Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Combose 0.5 Tablet
Label | Value |
---|---|
Addictive | None. |
Medication Classification | Medication for diabetes |